Morena M et al. |
Neurobiological Interactions Between Stress and the Endocannabinoid System. |
2016 |
Neuropsychopharmacology |
pmid:26068727
|
Dubreucq S et al. |
Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. |
2012 |
Neuropsychopharmacology |
pmid:22434220
|
Cristino L et al. |
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway Underlies Altered Pain Perception in Leptin Signaling Deficiency. |
2016 |
Neuropsychopharmacology |
pmid:26081302
|
DeVuono MV et al. |
Conditioned gaping produced by high dose Δ-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system. |
2018 |
Neuropharmacology |
pmid:30195587
|
Shonesy BC et al. |
The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium. |
2015 |
Neuropharmacology |
pmid:25484252
|
Atwood BK et al. |
CBâ‚‚ cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons. |
2012 |
Neuropharmacology |
pmid:22579668
|
Shimizu T et al. |
Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat. |
2015 |
Neuropharmacology |
pmid:25882827
|
Eroli F et al. |
Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing. |
2018 |
Neuropharmacology |
pmid:29225040
|
Walentiny DM et al. |
Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. |
2015 |
Neuropharmacology |
pmid:25698527
|
Kortleven C et al. |
Neurotensin inhibits glutamate-mediated synaptic inputs onto ventral tegmental area dopamine neurons through the release of the endocannabinoid 2-AG. |
2012 |
Neuropharmacology |
pmid:22884466
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
Pasquarelli N et al. |
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue. |
2015 |
Neuropharmacology |
pmid:25497453
|
Morena M et al. |
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety. |
2016 |
Neuropharmacology |
pmid:27553121
|
Vellani V et al. |
Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. |
2008 |
Neuropharmacology |
pmid:18329052
|
Darmani NA et al. |
Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew. |
2005 |
Neuropharmacology |
pmid:15921709
|
Desroches J et al. |
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CBâ‚ and CBâ‚‚ receptors. |
2014 |
Neuropharmacology |
pmid:24148808
|
Morgan NH et al. |
Functional CB2 type cannabinoid receptors at CNS synapses. |
2009 |
Neuropharmacology |
pmid:19616018
|
Wilkerson JL et al. |
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. |
2017 |
Neuropharmacology |
pmid:27890602
|
Piomelli D |
The endogenous cannabinoid system and the treatment of marijuana dependence. |
2004 |
Neuropharmacology |
pmid:15464150
|
Placzek EA et al. |
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. |
2008 |
Neuropharmacology |
pmid:18760289
|